Neurological Symptoms
Seizures, intellectual disability, ataxia, muscle weakness, dystonia, spasticity, and neuropathy are among the most common features across hundreds of rare neurological and neuromuscular conditions. Onset patterns (infantile vs. adult) and progression rate help narrow the differential diagnosis significantly.
Cardiac & Hematologic Signs
Cardiomyopathy, arrhythmias, anemia, easy bruising, and coagulation disorders can point to inherited metabolic storage diseases, connective tissue disorders, or primary hematologic conditions. Bleeding phenotypes combined with family history are particularly informative for rare coagulopathies.
Kidney & Urinary Features
Proteinuria, hematuria, renal cysts, and progressive renal insufficiency characterize numerous rare kidney diseases including IgA nephropathy, Alport syndrome, polycystic kidney disease, and Fabry disease. Early detection through urinalysis is often the first diagnostic clue.
Eye & Vision Changes
Retinal dystrophy, lens subluxation, corneal opacity, and progressive vision loss appear in more than 2,300 of the rare conditions Orphanet has annotated with eye findings. Ophthalmologic examination can reveal characteristic findings that help distinguish Marfan syndrome, homocystinuria, Fabry disease, and many lysosomal storage disorders.
Liver & Gastrointestinal
Hepatomegaly, splenomegaly, liver fibrosis, chronic diarrhea, and feeding difficulties are hallmarks of many metabolic, lysosomal storage, and mitochondrial disorders. Unexplained organomegaly in a child should prompt consideration of Gaucher disease, Niemann-Pick disease, and related conditions.
Skin & Skeletal Features
Short stature, facial dysmorphism, joint hypermobility, skeletal dysplasia, and skin findings such as ichthyosis or abnormal pigmentation can suggest specific genetic syndromes. Connective tissue findings like hyperextensible skin help distinguish conditions such as Ehlers-Danlos syndrome.
Respiratory Findings
Recurrent pneumonia, pulmonary fibrosis, bronchiectasis, and restrictive lung disease appear in conditions including cystic fibrosis, primary ciliary dyskinesia, alpha-1 antitrypsin deficiency, and pulmonary Langerhans cell histiocytosis.
Metabolic Abnormalities
Hypoglycemia, metabolic acidosis, lactic acidosis, hyperammonemia, and elevated liver enzymes detected on routine blood work can be early indicators of inborn errors of metabolism including urea cycle disorders, organic acidemias, and mitochondrial diseases.
How Symptom-Based Rare Disease Matching Works
▼
This tool uses an information-theoretic scoring approach inspired by the LIRICAL diagnostic framework developed at the Jackson Laboratory. When you select symptoms, each one is weighted by how diagnostically specific it is: a rare symptom like angiokeratoma (which appears in only a handful of diseases) carries far more diagnostic weight than a common one like headache. The algorithm then calculates a composite match score for each candidate disease based on the proportion of selected symptoms that match known phenotype associations, how rare those matching symptoms are across the disease landscape, and the known frequency of each symptom in the matched condition.
Results are ranked by diagnostic plausibility rather than simple symptom count, so selecting a few highly specific symptoms often produces more useful results than selecting many non-specific ones. This tool queries the Orphanet phenotype database in real time, meaning results reflect the most current disease-phenotype associations maintained by the international Orphanet consortium.
How accurate is this symptom finder for rare diseases?
▼
This tool uses clinical phenotype data from Orphanet, one of the world's most comprehensive rare disease databases, maintained by an international consortium of expert clinicians and funded by the European Commission and French National Institute of Health. The symptom-disease associations are curated by medical professionals. However, this tool provides candidate diagnoses for discussion with your doctor, not definitive medical diagnoses.
What is the Human Phenotype Ontology (HPO)?
▼
The HPO is a standardized vocabulary of over 20,000 clinical terms developed by the Monarch Initiative and medical geneticists worldwide. It provides a precise, structured way to describe symptoms and clinical findings so they can be computationally matched to known disease phenotypes. The HPO is used by clinical geneticists, diagnostic laboratories, and rare disease registries globally.
Why does selecting fewer, more specific symptoms sometimes give better results?
▼
The scoring algorithm weights symptoms by their diagnostic specificity. A symptom that occurs in only 2-3 rare diseases is far more informative than one appearing in hundreds of conditions. Selecting a small number of highly distinctive symptoms often pinpoints the right diagnosis more effectively than a long list of non-specific findings.
How is this different from a general symptom checker?
▼
General symptom checkers focus on common conditions. This tool is specifically designed for rare diseases, using the Orphanet database of 4,000+ rare conditions with their known phenotype associations. It uses HPO-coded phenotypes rather than free-text symptom descriptions, which enables precise matching against clinically curated disease profiles.
Can I use this tool to find clinical trials for my condition?
▼
Yes. When a matching disease has active clinical trials, this tool links directly to the Trial Friend disease page where you can explore currently recruiting trials, see trial locations on a map, and review eligibility criteria. Trial data is sourced from ClinicalTrials.gov, the official U.S. registry maintained by the National Library of Medicine.
What should I do after getting results from this tool?
▼
Print or save your results and bring them to your next appointment with your healthcare provider. If results suggest a genetic condition, ask your doctor about genetic testing or a referral to a clinical geneticist. Many rare diseases can be confirmed through targeted genetic panels, whole exome sequencing, or specific biochemical tests.
